Myelo Therapeutics develops innovative treatments in areas of high unmet medical needs.
Myelo Therapeutics has raised $17.4M in total funding. The most recent round was Grant. The last funding was announced in August 2022.
Myelo Therapeutics's investors include IBB Ventures, European Commission.
Myelo Therapeutics is headquartered in Berlin, Germany.
Myelo Therapeutics develops innovative treatments in areas of high unmet medical needs.
Myelo Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Myelo Therapeutics — Funding & Investors." VCBacked, August 4, 2022, https://www.vcbacked.co/company/myelo-therapeutics. Accessed August 13, 2026.
VCBacked. (2022). Myelo Therapeutics — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/myelo-therapeutics
{{cite web |title=Myelo Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/myelo-therapeutics |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated